According to Khairy, Malaysia will stick with AstraZeneca.

WhatsAppWhatsAppFacebookFacebookTwitterTwitterPinterestPinterestRedditRedditGmailGmailShareShare

PUTRAJAYA: According to National Covid-19 Immunisation Programme coordinating minister Khairy Jamaluddin, Malaysia will continue with the purchasing of AstraZeneca Covid-19 vaccines because there is no proof that the vaccine triggers blood clots.

He said that AstraZeneca had told Malaysia about the vaccine’s side effects, and that no evidence has been found to link the vaccine to cases of blood clots in people, which have resulted in deaths in a few countries.

Related Posts

“As of now, we will stick by our stand. The purchase of the AstraZeneca vaccines remains,” he told a joint press conference with health minister Dr Adham Baba on the development of the immunisation programme today.

Following reports of blood clots occurring in some people after being vaccinated, several nations, including Denmark, Norway, Iceland, and Thailand, have reportedly halted the roll-out of AstraZeneca’s vaccine. Several batches of the vaccine have also been discontinued in Italy and Austria.

Khairy, the minister of science, technology, and innovation, confirmed that the ministry would review clinical evidence from foreign events in order for experts to draw conclusions regarding vaccine use.

The National Pharmaceutical Regulatory Division (NPRA), according to Adham, performs extensive research on any vaccine that is to be used in Malaysia.

“We trust the NPRA’s decisions, and in the case of the AstraZeneca vaccine, we have looked into its quality and safety,” he said.

The conditional registration of AstraZeneca’s Covid-19 vaccine was approved by the Drug Control Authority on March 2.

In another matter, Khairy claimed that for the first phase of the immunisation program, Malaysia will receive additional Pfizer-BioNTech vaccines in stages.

He said that 83,070 doses of the Pfizer-BioNTech vaccine were shipped today, with another 124,020 doses arriving on March 22 and another 125,190 doses arriving on March 26.

“Cumulatively, Malaysia will receive 1,000,350 doses of vaccine and this completes the delivery for the first quarter,” he said, adding that 100,000 doses of Sinovac vaccine were also delivered today.

When asked why Malaysia purchased large quantities of Covid-19 vaccines, Khairy clarified that the bulk procurement was made to assist with the mitigation process, which includes reducing the possibility of vaccine delivery delays to Malaysia.

Katherine S

1/4 German, 3/4 Malaysian. I write, follow and monitor closely political news happening in Malaysia, and other happening news in the ASEAN region. Newswriter for the best ASEAN news website - The Asian Affairs.

Recent Posts

Singapore Expands Travel Advisory for India-Pakistan Border Regions

The Ministry of Foreign Affairs (MFA) in Singapore has upped its travel warning for Singaporeans by advising against travelling to…

May 8, 2025

34th Seoul Music Awards 2025: Nominees, Date, Venue, and Presenter

With the aim of honoring the stellar performers and achievers in the music industry of South Korea, the yearly prestigious…

May 8, 2025

Cocomelon Live Debuts in Singapore with Blippi at Marina Bay Sands

Children’s favourite and globally acclaimed ‘Cocomelon’ is known for their appealing animated videos which features nursery rhymes, educational songs, and…

May 8, 2025

ExecuJet MRO Services Malaysia Secures Historic Japanese Certification for Falcon 2000EX Maintenance

ExecuJet MRO Services Malaysia has a reason to smile as its maintenance, repair and overhaul (MRO) received the Japan Civil…

May 8, 2025

Sony Xperia 1 VII soon to launch in Japan this May 2025

Sony is known for catering premium quality in all types of electronics products they make for their users with their…

May 8, 2025

EU and Singapore Sign Landmark Digital Trade Agreement to Boost Innovation and Economic Ties

The European Union and Singapore agreed to a transformative Digital Trade Agreement which serves to deepen their economic relations through…

May 8, 2025